CPhI Milan 2026: Meet Datwyler at Booth #11A73
Two Datwyler Experts on Stage at the World's Largest Pharma Event
From Infusion to Self-Injection: Datwyler at the Center of Subcutaneous Delivery Innovation
CPHI Milan is the largest pharmaceutical ingredients and technology event on Earth — and Datwyler is bringing its full container closure and drug delivery component portfolio to this showcase, engaging manufacturers, CDMOs, and regulatory professionals from across Europe, Asia, and the Americas.
About Our Presentations
Datwyler takes the stage twice at CPHI Milan 2026. Paolo Ferrigno presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on Wednesday, October 7 at 1:45 PM, and Robert Lindner joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma," examining device trade-offs, market adoption realities, and patient preferences for large-volume subcutaneous delivery.
Want to connect?
Visit Booth #11A73 or book a meeting with our team to explore Datwyler's comprehensive portfolio of:
- The first-to-market 20ml universal NeoFlex™ plunger for large-volume injectables
- High-performance NeoFlex™ and OmniFlex® elastomer platforms for biologic drug delivery
All reflecting the full scope of modern pharmaceutical packaging needs, supported by Datwyler's Zero-Defect approach to faster development timelines and compliant manufacturing outcomes.
Presentation Details
From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery
Paolo Ferrigno, Product Manager, Prefilled Syringes and Cartridges at Datwyler, presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on Wednesday, October 7 at 1:45 PM.
- Examine the industry shift from IV infusion to subcutaneous self-administration and what it means for drug delivery system and component design
- Explore how plunger performance, coating technology, and formulation compatibility requirements are evolving to meet the demands of large-volume and home-based subcutaneous delivery
- Understand how the NeoFlex™ plunger platform supports the next generation of prefilled syringe and cartridge systems across biologics and GLP-1 applications
Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma
Robert Lindner, Global Platform Leader, Biologics at Datwyler, joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma," moderated by Clare Beddoes, Head of Drug Delivery at Cambridge Design Partnership.
- Comparing device trade-offs in wear time, injection duration, and patient acceptance between on-body platforms and large-format auto-injectors
- Examining why multiple smart device solutions exist but none have achieved widespread market adoption
- Incorporating patient group perspectives on usability, lifestyle impact, and adherence barriers for volumes exceeding 2mL
Panelists include Sara Stewart, Public Relations Communications Specialist & Patient Advocate; Soren Skov, Senior Human Factors Engineer at Roche; and Noah Flajsing, Associate Director Marketing at BD.
Meet the Speakers
Robert Lindner
Robert Lindner is the Global Platform Leader, Biologics at Datwyler, where he focuses on elastomeric closure solutions for biologic drug products. He brings over seven years of expertise in building global platforms for primary packaging containers, along with extensive experience in fill-and-finish processes, managing international R&D projects, and building global technology networks. Robert holds a PhD in Physical Chemistry from Mainz University.
What We're Showcasing at CPHI Milan
Explore the solutions and technologies most relevant to this event.
First-to-Market 20ml Universal Plunger for Large-Volume Injectables
High-Performance Components for Biologic Drug Delivery
A Strategic Partner for Pharmaceutical Growth
Continue Exploring
Access additional materials and information related to this event and Datwyler’s solutions.